Early Events after Herpes Simplex Virus-Type 1 Entry Are Necessary for the Release of Gamma-Hydroxybutyrate upon Acute Infection

We reported that gamma-hydroxybutyrate (GHB) is released upon Herpes Simplex Virus Type-1 (HSV-1) acute infection. However, the cellular biochemical processes involved in the production of GHB in infected cells are unclear. This study aims to shed light on the biochemical pathway and the stage within the viral life cycle responsible for the release of GHB in infected cells. UV-inactivation, acyclovir (ACV), and cycloheximide (CHX) treatments were used to inhibit HSV-1 replication at various stages. Vero cells treated with UV-inactivated HSV-1 significantly decreased GHB production. However, ACV or CHX treatments did not affect GHB production. We also showed that inhibition of glycolytic enzyme enolase by sodium fluoride (NaF) significantly reduces GHB production upon infection. This finding suggests that suppression of glycolytic activity negatively affects cellular GHB production. Our data also indicated that succinic semialdehyde dehydrogenase, an enzyme involved in the shunt of the tricarboxylic acid (TCA) cycle to generate succinic acid, was decreased upon infection, suggesting that infection may trigger the accumulation of succinic semialdehyde, causing the production of GHB. Although the precise mechanism has yet to be defined, our results suggest that early events following infection modulates the release of GHB, which is generated through the metabolic pathways of glycolysis and TCA cycle.

An assay to screen bacterial adhesion to mucus biomolecules

AIMS

To develop an assay for rapid screening of bacterial adhesion to various groups of biomolecules present in fish mucus.

METHODS AND RESULTS

A novel assay was developed for investigation of bacterial adhesion to various groups of mucus biomolecules from fish. Lipid-, protein-, carbohydrate- and nucleic acid-rich constituents of mucus were separated using isopycnic density gradient centrifugation techniques. Separated mucus fractions were assayed for bacterial adhesion using a blotting apparatus. The assay was validated using Vibrio vulnificus and skin mucus from hybrid tilapia.

CONCLUSIONS

A novel assay was developed for the screening of bacterial adhesion to major groups of mucus biomolecules. Adhesion of V. vulnificus MLT403 positively correlated with lipid- and protein-rich mucus constituents and negatively correlated with carbohydrate-rich mucus constituents.

SIGNIFICANCE AND IMPACT OF THE STUDY

The assay can be used as an initial approach in a systematic identification of mucus constituent(s) exhibiting the most favourable adhesion properties for bacteria.